Indo SMC FY26 Results (BSE: 544681)
Signal: Steady quarter
The read
FY26 is a landmark year — revenue tripled to ₹310 Cr and PAT nearly doubled to ₹32 Cr, powered by the CT PT Products segment which went from a small contributor to the dominant business line. The gross margin tailwind of ~1200 bps (cost of materials % fell from 95.4% to 83.4%) was a major positive, but operating EBITDA margin actually compressed ~170 bps as other expenditure (SG&A) grew 187% YoY, far outpacing revenue growth. Crucially, the business burned ₹34.8 Cr in operating cash flow due to a massive ₹67.8 Cr inventory build — a red flag for working capital management. The IPO provided ₹85 Cr in fresh equity, converting net debt of ₹32.9 Cr to net cash of ₹6.6 Cr. EPS dilution from the capital raise tempered per-share growth, but at P/E of ~31x, the market is pricing in continued CT PT momentum and an eventual improvement in cash conversion.
| Metric | Value | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹309.74 Cr | +123.32% | |
| EBIT | ₹40.54 Cr | +112.12% | |
| Net profit | ₹32.38 Cr | +92.39% | |
| EPS | ₹18.09 | +72.61% |
P&L walk
FY26 standalone revenue of ₹309.74 Cr (+123% YoY) and PAT of ₹32.38 Cr (+92% YoY) reflect strong topline expansion, but the profit growth lagged revenue due to a sharp increase in other expenditure (from ₹9.83 Cr to ₹28.21 Cr), which grew faster than sales. Cost of materials improved as a % of revenue (83.35% vs 95.38% in FY25 — a 1203 bps tailwind), yet the gross margin benefit was partly offset by higher other costs. H2 (Oct'25-Mar'26) was particularly strong: revenue ₹197.20 Cr (+186% YoY) and PAT ₹20.93 Cr (+344% YoY). EPS rose to ₹18.09 from ₹10.48, but lagged PAT growth due to equity dilution from IPO (shares increased from 166.84 lakh to 228.55 lakh). Finance cost grew to ₹5.67 Cr (+60% YoY) but remains manageable. The business generated negative operating cash flow (-₹34.77 Cr) driven by a massive inventory build (+₹67.85 Cr).
Segments
CT PT Products segment was the standout growth engine, its revenue surging over 12x to ₹222.02 Cr from ₹18.09 Cr and segment profit soaring to ₹27.04 Cr from ₹2.87 Cr — contributing 72% of total segment revenue and 59% of segment profit; SMC Products (-29% revenue) and FRP Products (-21% revenue) declined, though both maintained positive segment profits. Total segment profit grew 104% YoY to ₹46.21 Cr.
Key positives
- CT PT Products segment revenue grew 12x to ₹222.02 Cr, driving overall revenue growth of +123%.
- Cost of materials as % of revenue improved by 1203 bps (83.35% vs 95.38%), indicating strong gross margin expansion.
- Swung from net debt of ₹32.88 Cr to net cash of ₹6.60 Cr following IPO proceeds — balance sheet strengthened significantly.
- H2 (Oct'25-Mar'26) showed accelerating momentum: +186% revenue and +344% PAT YoY.
- Employee cost grew slower than revenue (65% vs 123%), providing some operating leverage.
Key concerns
- EPS growth (72.6%) materially lagged PAT growth (92.4%) due to 37% equity dilution from IPO.
- Operating cash flow deeply negative at -₹34.76 Cr due to a ₹67.85 Cr inventory build — working capital stress.
- Other expenditure (SG&A) grew 187% YoY to ₹28.21 Cr, far outpacing revenue growth and compressing EBITDA margin.
- SMC Products and FRP Products segments declined 29% and 21% respectively — single-segment concentration risk emerges.
- Trade payables declined by ₹5.74 Cr (to ₹14.44 Cr), suggesting less supplier credit being used to finance growth.
Research and educational content only. Not investment advice.